Felix AM - Search Results

1

The Alzheimer's peptide a beta adopts a collapsed coil structure in water.

Zhang S, Iwata K, Lachenmann MJ, Peng JW, Li S, Stimson ER, Lu Y, Felix AM, Maggio JE, Lee JP. Zhang S, et al. Among authors: felix am. J Struct Biol. 2000 Jun;130(2-3):130-41. doi: 10.1006/jsbi.2000.4288. J Struct Biol. 2000. PMID: 10940221 Free article.

2

Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence.

Esler WP, Stimson ER, Ghilardi JR, Lu YA, Felix AM, Vinters HV, Mantyh PW, Lee JP, Maggio JE. Esler WP, et al. Among authors: felix am. Biochemistry. 1996 Nov 5;35(44):13914-21. doi: 10.1021/bi961302+. Biochemistry. 1996. PMID: 8909288

3

Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid.

Esler WP, Felix AM, Stimson ER, Lachenmann MJ, Ghilardi JR, Lu YA, Vinters HV, Mantyh PW, Lee JP, Maggio JE. Esler WP, et al. Among authors: felix am. J Struct Biol. 2000 Jun;130(2-3):174-83. doi: 10.1006/jsbi.2000.4276. J Struct Biol. 2000. PMID: 10940224

4

1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.

Lee JP, Stimson ER, Ghilardi JR, Mantyh PW, Lu YA, Felix AM, Llanos W, Behbin A, Cummings M, Van Criekinge M, et al. Lee JP, et al. Among authors: felix am. Biochemistry. 1995 Apr 18;34(15):5191-200. doi: 10.1021/bi00015a033. Biochemistry. 1995. PMID: 7711039

5

A beta deposition inhibitor screen using synthetic amyloid.

Esler WP, Stimson ER, Ghilardi JR, Felix AM, Lu YA, Vinters HV, Mantyh PW, Maggio JE. Esler WP, et al. Among authors: felix am. Nat Biotechnol. 1997 Mar;15(3):258-63. doi: 10.1038/nbt0397-258. Nat Biotechnol. 1997. PMID: 9062926

6

Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.

Lu YA, Felix AM. Lu YA, et al. Among authors: felix am. Int J Pept Protein Res. 1994 Feb;43(2):127-38. Int J Pept Protein Res. 1994. PMID: 8200730

7

Pegylated peptides I: Solid-phase synthesis of N alpha-pegylated peptides using Fmoc strategy.

Lu YA, Felix AM. Lu YA, et al. Among authors: felix am. Pept Res. 1993 May-Jun;6(3):140-6. Pept Res. 1993. PMID: 8318745

8

Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.

Felix AM, Lu YA, Campbell RM. Felix AM, et al. Int J Pept Protein Res. 1995 Sep-Oct;46(3-4):253-64. Int J Pept Protein Res. 1995. PMID: 8537179

9

Restoration of the transcription activation function to mutant p53 in human cancer cells.

Abarzúa P, LoSardo JE, Gubler ML, Spathis R, Lu YA, Felix A, Neri A. Abarzúa P, et al. Oncogene. 1996 Dec 5;13(11):2477-82. Oncogene. 1996. PMID: 8957091

10

Synthesis, biological activity and conformational analysis of cyclic GRF analogs.

Felix AM, Heimer EP, Wang CT, Lambros TJ, Fournier A, Mowles TF, Maines S, Campbell RM, Wegrzynski BB, Toome V, et al. Felix AM, et al. Int J Pept Protein Res. 1988 Dec;32(6):441-54. doi: 10.1111/j.1399-3011.1988.tb01375.x. Int J Pept Protein Res. 1988. PMID: 3149952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters